74
Views
7
CrossRef citations to date
0
Altmetric
Review

New developments in the treatment of chronic lymphocytic leukemia: role of obinutuzumab

Pages 1113-1122 | Published online: 28 Jul 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Leonid Dubrovsky, Elliott Joseph Brea, Dmitry Pankov, Emily Casey, Tao Dao, Cheng Liu & David A. Scheinberg. (2016) Mechanisms of leukemia resistance to antibody dependent cellular cytotoxicity. OncoImmunology 5:9.
Read now

Articles from other publishers (6)

O.V. Muzhychuk, N.V. Bezditko, O.Ya. Mishchenko & I.V. Muzhychuk. (2022) Pharmacoeconomic analysis of cost-effectiveness when using obinutuzumab (Gazyva ® drug) in treating chronic lymphocytic leukemia in Ukraine. Український радіологічний та онкологічний журнал 30:4, pages 28-38.
Crossref
Bernard L Marini, Lisa Samanas & Anthony J Perissinotti. (2016) Expanding the armamentarium for chronic lymphocytic leukemia: A review of novel agents in the management of chronic lymphocytic leukemia. Journal of Oncology Pharmacy Practice 23:7, pages 502-517.
Crossref
R. Ajina, D. AlDeghaither, S. Jablonski & L.M. Weiner. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III 32 65 .
Roy Jefferis. 2021. Advances in Glycobiotechnology. Advances in Glycobiotechnology 281 318 .
Silvia Sánchez-Ramón, Fatima Dhalla & Helen Chapel. (2016) Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological Malignancy. Frontiers in Immunology 7.
Crossref
Yurii Ivanovich Budchanov. (2016) Monoclonal Antibodies: from Development to Clinical Application. Clinical oncohematology 9:3, pages 237-244.
Crossref